Detalhe da pesquisa
1.
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Int J Cancer
; 143(4): 958-970, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508386
2.
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 25(24): 7540-7553, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578228
3.
NOTCH and Graft-Versus-Host Disease.
Front Immunol
; 9: 1825, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30147692
4.
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.
Front Oncol
; 8: 105, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29732315
5.
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.
Int J Hematol
; 106(6): 860-864, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28721499
6.
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.
Br J Haematol
; 151(4): 404-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813007
7.
A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.
PLoS One
; 8(7): e68080, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874502